BIOLASE TECHNOLOGY INC
10-Q, EX-27, 2000-11-14
DENTAL EQUIPMENT & SUPPLIES
Previous: BIOLASE TECHNOLOGY INC, 10-Q, 2000-11-14
Next: WORLDWATER CORP, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED CONDENSED BALANCE SHEET AT SEPTEMBER 30, 2000 AND ITS
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE-MONTH
PERIODS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             JUL-01-2000             JAN-01-2000
<PERIOD-END>                               SEP-30-2000             SEP-30-2000
<CASH>                                       1,316,067               1,316,067
<SECURITIES>                                         0                       0
<RECEIVABLES>                                1,396,750               1,396,750
<ALLOWANCES>                                 (147,745)               (147,745)
<INVENTORY>                                  1,352,535               1,352,535
<CURRENT-ASSETS>                             4,094,581               4,094,581
<PP&E>                                       3,599,850               3,599,850
<DEPRECIATION>                             (1,217,605)             (1,217,605)
<TOTAL-ASSETS>                               6,599,388               6,599,388
<CURRENT-LIABILITIES>                        3,865,492               3,865,492
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                        19,281                  19,281
<OTHER-SE>                                   1,535,101               1,535,101
<TOTAL-LIABILITY-AND-EQUITY>                 6,599,388               6,599,388
<SALES>                                      2,187,168               5,973,000
<TOTAL-REVENUES>                             2,187,168               5,973,000
<CGS>                                        1,185,303               3,395,820
<TOTAL-COSTS>                                1,185,303               3,395,820
<OTHER-EXPENSES>                               575,615               1,692,793
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              36,922                  94,302
<INCOME-PRETAX>                            (1,164,714)             (3,084,586)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (1,164,714)             (3,084,586)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,164,714)             (3,084,586)
<EPS-BASIC>                                     (0.06)                  (0.16)
<EPS-DILUTED>                                   (0.06)                  (0.16)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission